부인과용 의자 및 테이블 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 용도별, 최종 용도별, 지역별, 부문별 예측(2025-2030년)

Gynecological Chairs And Tables Market Size, Share & Trends Analysis Report By Product (Gynecological Chairs, Gynecological Tables), By Application (Urology Surgery, Pelvic Surgery), By End Use, By Region, And Segment Forecasts, 2025 - 2030

US $ 5,950 ￦ 8,194,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 9,571,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 12,325,000

Printable PDF & Excel (Enterprise License)

보고서 구매 기업 및 그 자회사, 관계사가 사용할 수 있는 라이선스이며, PDF 및 엑셀 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능합니다.

한글목차

부인과용 의자 및 테이블 시장의 성장과 동향

Grand View Research, Inc의 최신 보고서에 따르면 부인과용 의자 및 테이블 세계 시장 규모는 2030년에 10억 4,079만 달러에 달할 것으로 예측되며, 2025-2030년에 걸쳐 CAGR 6.23%로 성장할 것으로 전망됩니다.

이 시장에는 정기적인 골반 검사, 팝스메어, 코르포스카피, 질암 검진, 생검, 산과 검진, IUD 삽입 및 제거, 동결요법 등 다양한 여성의 건강 처치에 맞춘 전용 가구가 포함됩니다. 미국 임상종양학회(ASCO)에 따르면 2020년에는 세계 전체에서 약 1만 7,908명이 질암 진단을 받고, 2023년에는 미국에서만 추정 8,470명이 이 질환으로 진단될 것으로 예측되고 있습니다.

기술의 진보로 원격 의료 플랫폼과의 통합이 가능해 원격 검사나 진찰을 할 수 있게 되었습니다.

최신 부인과용 의자 및 테이블은 검사 및 치료 중 환자의 편안함을 최우선으로 하고 있습니다. 게다가, 내하중의 향상이나 긴급정지 버튼 등의 안전기능도 중요합니다.

부인과용 의자 및 테이블 시장 보고서 하이라이트

• 부인과용 의자 부문은 2024년에 44.54%의 최대 시장 점유율을 차지했습니다.
• 골반 수술 부문은 2024년에 37.75%의 큰 수익 점유율을 차지했습니다.
• 오피스 기반의 수술(OBS) 부문은 2024년에 34.19%의 큰 수익 점유율을 차지했습니다. 오피스 기반의 수술이란, 의사 면허를 가지는 사람이 사무실에서 실시하는 수술입니다.
• 퇴역 군인성(VA) 부문은 예측 기간 동안 7.54%의 가장 빠른 CAGR로 성장할 것으로 예상됩니다.
• 북미 부인과용 의자 및 테이블 산업은 2024년 세계를 석권해 38.14%의 수익 점유율을 차지했습니다.

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 부인과용 의자 및 테이블 시장의 변수, 동향, 범위

• 시장 계통의 전망
  • 모 시장 전망
  • 관련, 부수 시장 전망
• 시장 역학
  • 시장 성장 촉진요인 분석
  • 시장 성장 억제요인 분석
• 부인과용 의자 및 테이블 시장 분석 툴
  • 산업 분석 - Porter's Five Forces 분석
  • PESTEL 분석

제4장 부인과용 의자 및 테이블 시장 : 제품별, 추정 및 예측 분석

• 부문 대시보드
• 부인과용 의자 및 테이블 시장 : 제품 변동 분석
• 부인과용 의자 및 테이블 시장 : 제품 전망별
• 2018-2030년 시장 규모와 예측과 동향 분석
• 부인과용 의자
• 부인과용 테이블
• 수술대 부츠의 아부미

제5장 부인과용 의자 및 테이블 시장 : 용도별, 추정 및 예측 분석

• 부문 대시보드
• 부인과용 의자 및 테이블 시장 : 용도 변동 분석
• 부인과용 의자 및 테이블 시장 : 용도 전망
• 2018-2030년 시장 규모와 예측과 동향 분석
• 비뇨기과 수술
• 골반 수술

제6장 부인과용 의자 및 테이블 시장 : 최종 용도별, 추정 및 예측 분석

• 부문 대시보드
• 부인과용 의자 및 테이블 시장 : 최종 용도 변동 분석
• 부인과용 의자 및 테이블 시장 : 최종 용도 전망
• 2018-2030년 시장 규모와 예측과 동향 분석
• 퇴역군인성(VA)
• 사무실 기반 수술(OBS)
• 기타

제7장 부인과용 의자 및 테이블 시장 : 지역별, 추정 및 예측 분석

• 지역 대시보드
• 지역별 부인과용 의자 및 테이블 시장 변동 분석
• 부인과용 의자 및 테이블 시장 :기술·최종 용도에 의한 지역 추정 및 예측 분석
• 2018-2030년 시장 규모와 예측과 동향 분석
• 북미
  • 미국
  • 캐나다
  • 멕시코
• 유럽
  • 영국
  • 독일
  • 프랑스
  • 이탈리아
  • 스페인
  • 덴마크
  • 스웨덴
  • 노르웨이
• 아시아태평양
  • 일본
  • 중국
  • 인도
  • 한국
  • 호주
  • 태국
• 라틴아메리카
  • 브라질
  • 아르헨티나
• 중동 및 아프리카
  • 남아프리카
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 쿠웨이트

제8장 경쟁 구도

• 시장 진출기업의 분류
• 주요 기업 프로파일
  • STERIS
  • Optomic
  • medifa
  • Advin Health Care
  • MERIVAARA CORP.
  • Apothecaries Sundries Manufacturing Co.
  • Novak M.
  • Zhangjiagang Medi Medical Equipment Co., ltd.
  • Surgitech
  • The Brewer Company, LLC
  • Midmark Corporation.(Ritter Midmark)
  • Clinton Industries, Inc.
  • UMF Medical
  • Hausmann Enterprises, LLC
  • Bailey's Medical Supplies
  • Metron Healthcare
  • Baxter(Hill Rom Holdings) Company overview

SHW

영문 목차

영문목차

Gynecological Chairs And Tables Market Growth & Trends:

The global gynecological chairs and tables market size is expected to reach USD 1,040.79 million in 2030 and is projected to grow at a CAGR of 6.23% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market encompasses specialized furniture tailored for various women's health procedures, including routine pelvic exams, pap smears, colposcopy, vaginal cancer screenings, biopsies, obstetrics, IUD insertion and removal, and cryotherapy. For instance, according to the American Society of Clinical Oncology (ASCO), globally, around 17,908 individuals received a diagnosis of vaginal cancer in 2020, and in 2023, an estimated 8,470 people in the U.S. alone are projected to be diagnosed with this condition.

Technological advancements enable integration with telemedicine platforms, allowing for remote examinations and consultations. With a focus on improving patient care and clinical outcomes, the market continues to evolve to meet the diverse needs of healthcare providers and patients in women's health.

Modern gynecological chairs and tables prioritize patient comfort during examinations and procedures. This includes features such as adjustable positioning, memory settings, and integrated heating for a more relaxed and positive patient experience. In addition, safety features such as weight capacity improvements and emergency stop buttons are crucial. Hence, the increasing focus of manufacturers on developing equipment that offers patient comfort and safety is anticipated to create wide growth opportunities in the near future.

Gynecological Chairs And Tables Market Report Highlights:

• The gynecological chairs segment held the largest market share of 44.54% in 2024. These chairs are designed to provide comfort, accessibility, and support during gynecological examinations, surgeries, and treatments
• The pelvic surgery segment held a significant revenue share of 37.75% in 2024. Due to the large number of individuals suffering from pelvic conditions such as Pelvic Organ Prolapse (POP), the segment is anticipated to witness significant growth in the coming years
• The Office-based surgery (OBS) segment held a significant revenue share of 34.19% in 2024. Office-based surgery is any procedure that a licensed physician performs in an office setting.
• The Department of Veterans Affairs (VA) segment shows the fastest CAGR of 7.54% over the forecast period
• The North American gynecological chairs and tables industry dominated globally in 2024 and held a revenue share of 38.14%. Some key factors contributing to the growth include the presence of numerous key players, a well-established healthcare infrastructure, growing awareness among the female population

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.1. Segment Definitions
  • 1.1.1. Product
  • 1.1.2. Application
  • 1.1.3. End Use
  • 1.1.4. Regional scope
  • 1.1.5. Estimates and forecasts timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
    • 1.3.5.1. Data for primary interviews in North America
    • 1.3.5.2. Data for primary interviews in Europe
    • 1.3.5.3. Data for primary interviews in Asia Pacific
    • 1.3.5.4. Data for primary interviews in Latin America
    • 1.3.5.5. Data for Primary interviews in MEA
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
  • 1.6.2. Approach 1: Commodity flow approach
  • 1.6.3. Volume price analysis (Model 2)
  • 1.6.4. Approach 2: Volume price analysis
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product outlook
  • 2.2.2. Application outlook
  • 2.2.3. End-Use Outlook
• 2.3. Regional outlook
• 2.4. Competitive Insights

Chapter 3. Gynecological Chairs and Tables Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Increasing prevalence of gynecological disorders
    • 3.2.1.2. Technological advancements
    • 3.2.1.3. Growing awareness of gynecological disorders and treatments
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. High cost of products and gynecological treatments
    • 3.2.2.2. Lack of healthcare facilities and professionals in developing and underdeveloped countries
• 3.3. Gynecological Chairs and Tables Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic landscape
    • 3.3.2.3. Social landscape
    • 3.3.2.4. Technological landscape
    • 3.3.2.5. Environmental landscape
    • 3.3.2.6. Legal landscape

Chapter 4. Gynecological Chairs and Tables Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Gynecological Chairs and Tables Market: Product Movement Analysis
• 4.3. Gynecological Chairs and Tables Market by Product Outlook (Volume, Units; Revenue, USD Million)
• 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 4.5. Gynecological Chairs
  • 4.5.1. Gynecological Chairs Market Revenue Estimates and Forecasts, 2018 - 2030 (Volume, Units; Revenue, USD Million)
    • 4.5.1.1. Electric
      • 4.5.1.1.1. Electric Market Revenue Estimates and Forecasts, 2018 - 2030 (Volume, Units; Revenue, USD Million)
    • 4.5.1.2. Manual
      • 4.5.1.2.1. Manual Market Revenue Estimates and Forecasts, 2018 - 2030 (Volume, Units; Revenue, USD Million)
• 4.6. Gynecological Tables
  • 4.6.1. Gynecological Tables Market Revenue Estimates and Forecasts, 2018 - 2030 (Volume, Units; Revenue, USD Million)
    • 4.6.1.1. Powered
      • 4.6.1.1.1. Powered Market Revenue Estimates and Forecasts, 2018 - 2030 (Volume, Units; Revenue, USD Million)
    • 4.6.1.2. Non-powered
      • 4.6.1.2.1. Non-powered Market Revenue Estimates and Forecasts, 2018 - 2030 (Volume, Units; Revenue, USD Million)
• 4.7. Operating Table Boot Stirrups
  • 4.7.1. Operating Table Boot Stirrups Market Revenue Estimates and Forecasts, 2018 - 2030 (Volume, Units; Revenue, USD Million)

Chapter 5. Gynecological Chairs and Tables Market: Application Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Gynecological Chairs and Tables Market: Application Movement Analysis
• 5.3. Gynecological Chairs and Tables Market by Application Outlook (Volume, Units; Revenue, USD Million)
• 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 5.5. Urology Surgery
  • 5.5.1. Urology Surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (Volume, Units; Revenue, USD Million)
• 5.6. Pelvic Surgery
  • 5.6.1. Pelvic Surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (Volume, Units; Revenue, USD Million)

Chapter 6. Gynecological Chairs and Tables Market: End Use Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Gynecological Chairs and Tables Market: End Use Movement Analysis
• 6.3. Gynecological Chairs and Tables Market by End Use Outlook (Volume, Units; Revenue, USD Million)
• 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 6.5. Department of Veterans Affairs (VA)
  • 6.5.1. Department of Veterans Affairs (VA) Market Revenue Estimates and Forecasts, 2018 - 2030 (Volume, Units; Revenue, USD Million)
• 6.6. Office-Based Surgery (OBS)
  • 6.6.1. Office-Based Surgery (OBS) Market Revenue Estimates and Forecasts, 2018 - 2030 (Volume, Units; Revenue, USD Million)
• 6.7. Others
  • 6.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Gynecological Chairs and Tables Market: Regional Estimates & Trend Analysis

• 7.1. Regional Dashboard
• 7.2. Regional Gynecological Chairs and Tables Market movement analysis
• 7.3. Gynecological Chairs and Tables Market: Regional Estimates & Trend Analysis by Technology & End Use
• 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 7.5. North America
  • 7.5.1. North America Gynecological Chairs and Tables Market Estimates and Forecasts, 2018 - 2030 (Volume, Units; Revenue, USD Million)
  • 7.5.2. U.S.
    • 7.5.2.1. Key Country Dynamics
    • 7.5.2.2. Competitive Scenario
    • 7.5.2.3. Regulatory Framework
    • 7.5.2.4. Reimbursement scenario
    • 7.5.2.5. U.S. Gynecological Chairs and Tables Market Estimates and Forecasts, 2018 - 2030 (Volume, Units; Revenue, USD Million)
  • 7.5.3. Canada
    • 7.5.3.1. Key Country Dynamics
    • 7.5.3.2. Competitive Scenario
    • 7.5.3.3. Regulatory Framework
    • 7.5.3.4. Reimbursement scenario
    • 7.5.3.5. Canada Gynecological Chairs and Tables Market Estimates and Forecasts, 2018 - 2030 (Volume, Units; Revenue, USD Million)
  • 7.5.4. Mexico
    • 7.5.4.1. Key Country Dynamics
    • 7.5.4.2. Competitive Scenario
    • 7.5.4.3. Regulatory Framework
    • 7.5.4.4. Reimbursement scenario
    • 7.5.4.5. Mexico Gynecological Chairs and Tables Market Estimates and Forecasts, 2018 - 2030 (Volume, Units; Revenue, USD Million)
• 7.6. Europe
  • 7.6.1. Europe Gynecological Chairs and Tables Market Estimates and Forecasts, 2018 - 2030 (Volume, Units; Revenue, USD Million)
  • 7.6.2. UK
    • 7.6.2.1. Key Country Dynamics
    • 7.6.2.2. Competitive Scenario
    • 7.6.2.3. Regulatory Framework
    • 7.6.2.4. Reimbursement scenario
    • 7.6.2.5. UK Gynecological Chairs and Tables Market Estimates and Forecasts, 2018 - 2030 (Volume, Units; Revenue, USD Million)
  • 7.6.3. Germany
    • 7.6.3.1. Key Country Dynamics
    • 7.6.3.2. Competitive Scenario
    • 7.6.3.3. Regulatory Framework
    • 7.6.3.4. Reimbursement scenario
    • 7.6.3.5. Germany Gynecological Chairs and Tables Market Estimates and Forecasts, 2018 - 2030 (Volume, Units; Revenue, USD Million)
  • 7.6.4. France
    • 7.6.4.1. Key Country Dynamics
    • 7.6.4.2. Competitive Scenario
    • 7.6.4.3. Regulatory Framework
    • 7.6.4.4. Reimbursement scenario
    • 7.6.4.5. France Gynecological Chairs and Tables Market Estimates and Forecasts, 2018 - 2030 (Volume, Units; Revenue, USD Million)
  • 7.6.5. Italy
    • 7.6.5.1. Key Country Dynamics
    • 7.6.5.2. Competitive Scenario
    • 7.6.5.3. Regulatory Framework
    • 7.6.5.4. Reimbursement scenario
    • 7.6.5.5. Italy Gynecological Chairs and Tables Market Estimates and Forecasts, 2018 - 2030 (Volume, Units; Revenue, USD Million)
  • 7.6.6. Spain
    • 7.6.6.1. Key Country Dynamics
    • 7.6.6.2. Competitive Scenario
    • 7.6.6.3. Regulatory Framework
    • 7.6.6.4. Reimbursement scenario
    • 7.6.6.5. Spain Gynecological Chairs and Tables Market Estimates and Forecasts, 2018 - 2030 (Volume, Units; Revenue, USD Million)
  • 7.6.7. Denmark
    • 7.6.7.1. Key Country Dynamics
    • 7.6.7.2. Competitive Scenario
    • 7.6.7.3. Regulatory Framework
    • 7.6.7.4. Reimbursement scenario
    • 7.6.7.5. Denmark Gynecological Chairs and Tables Market Estimates and Forecasts, 2018 - 2030 (Volume, Units; Revenue, USD Million)
  • 7.6.8. Sweden
    • 7.6.8.1. Key Country Dynamics
    • 7.6.8.2. Competitive Scenario
    • 7.6.8.3. Regulatory Framework
    • 7.6.8.4. Reimbursement scenario
    • 7.6.8.5. Sweden Gynecological Chairs and Tables Market Estimates and Forecasts, 2018 - 2030 (Volume, Units; Revenue, USD Million)
  • 7.6.9. Norway
    • 7.6.9.1. Key Country Dynamics
    • 7.6.9.2. Competitive Scenario
    • 7.6.9.3. Regulatory Framework
    • 7.6.9.4. Reimbursement scenario
    • 7.6.9.5. Norway Gynecological Chairs and Tables Market Estimates and Forecasts, 2018 - 2030 (Volume, Units; Revenue, USD Million)
• 7.7. Asia Pacific
  • 7.7.1. Asia Pacific Gynecological Chairs and Tables Market Estimates and Forecasts, 2018 - 2030 (Volume, Units; Revenue, USD Million)
  • 7.7.2. Japan
    • 7.7.2.1. Key Country Dynamics
    • 7.7.2.2. Competitive Scenario
    • 7.7.2.3. Regulatory Framework
    • 7.7.2.4. Reimbursement scenario
    • 7.7.2.5. Japan Gynecological Chairs and Tables Market Estimates and Forecasts, 2018 - 2030 (Volume, Units; Revenue, USD Million)
  • 7.7.3. China
    • 7.7.3.1. Key Country Dynamics
    • 7.7.3.2. Competitive Scenario
    • 7.7.3.3. Regulatory Framework
    • 7.7.3.4. Reimbursement scenario
    • 7.7.3.5. China Gynecological Chairs and Tables Market Estimates and Forecasts, 2018 - 2030 (Volume, Units; Revenue, USD Million)
  • 7.7.4. India
    • 7.7.4.1. Key Country Dynamics
    • 7.7.4.2. Competitive Scenario
    • 7.7.4.3. Regulatory Framework
    • 7.7.4.4. Reimbursement scenario
    • 7.7.4.5. India Gynecological Chairs and Tables Market Estimates and Forecasts, 2018 - 2030 (Volume, Units; Revenue, USD Million)
  • 7.7.5. South Korea
    • 7.7.5.1. Key Country Dynamics
    • 7.7.5.2. Competitive Scenario
    • 7.7.5.3. Regulatory Framework
    • 7.7.5.4. Reimbursement scenario
    • 7.7.5.5. South Korea Gynecological Chairs and Tables Market Estimates and Forecasts, 2018 - 2030 (Volume, Units; Revenue, USD Million)
  • 7.7.6. Australia
    • 7.7.6.1. Key Country Dynamics
    • 7.7.6.2. Competitive Scenario
    • 7.7.6.3. Regulatory Framework
    • 7.7.6.4. Reimbursement scenario
    • 7.7.6.5. Australia Gynecological Chairs and Tables Market Estimates and Forecasts, 2018 - 2030 (Volume, Units; Revenue, USD Million)
  • 7.7.7. Thailand
    • 7.7.7.1. Key Country Dynamics
    • 7.7.7.2. Competitive Scenario
    • 7.7.7.3. Regulatory Framework
    • 7.7.7.4. Reimbursement scenario
    • 7.7.7.5. Thailand Gynecological Chairs and Tables Market Estimates and Forecasts, 2018 - 2030 (Volume, Units; Revenue, USD Million)
• 7.8. Latin America
  • 7.8.1. Latin America Gynecological Chairs and Tables Market Estimates and Forecasts, 2018 - 2030 (Volume, Units; Revenue, USD Million)
  • 7.8.2. Brazil
    • 7.8.2.1. Key Country Dynamics
    • 7.8.2.2. Competitive Scenario
    • 7.8.2.3. Regulatory Framework
    • 7.8.2.4. Reimbursement scenario
    • 7.8.2.5. Brazil Gynecological Chairs and Tables Market Estimates and Forecasts, 2018 - 2030 (Volume, Units; Revenue, USD Million)
  • 7.8.3. Argentina
    • 7.8.3.1. Key Country Dynamics
    • 7.8.3.2. Competitive Scenario
    • 7.8.3.3. Regulatory Framework
    • 7.8.3.4. Reimbursement scenario
    • 7.8.3.5. Argentina Gynecological Chairs and Tables Market Estimates and Forecasts, 2018 - 2030 (Volume, Units; Revenue, USD Million)
• 7.9. Middle East & Africa
  • 7.9.1. Middle East & Africa Gynecological Chairs and Tables Market Estimates and Forecasts, 2018 - 2030 (Volume, Units; Revenue, USD Million)
  • 7.9.2. South Africa
    • 7.9.2.1. Key Country Dynamics
    • 7.9.2.2. Competitive Scenario
    • 7.9.2.3. Regulatory Framework
    • 7.9.2.4. Reimbursement scenario
    • 7.9.2.5. South Africa Gynecological Chairs and Tables Market Estimates and Forecasts, 2018 - 2030 (Volume, Units; Revenue, USD Million)
  • 7.9.3. Saudi Arabia
    • 7.9.3.1. Key Country Dynamics
    • 7.9.3.2. Competitive Scenario
    • 7.9.3.3. Regulatory Framework
    • 7.9.3.4. Reimbursement scenario
    • 7.9.3.5. Saudi Arabia Gynecological Chairs and Tables Market Estimates and Forecasts, 2018 - 2030 (Volume, Units; Revenue, USD Million)
  • 7.9.4. UAE
    • 7.9.4.1. Key Country Dynamics
    • 7.9.4.2. Competitive Scenario
    • 7.9.4.3. Regulatory Framework
    • 7.9.4.4. Reimbursement scenario
    • 7.9.4.5. UAE Gynecological Chairs and Tables Market Estimates and Forecasts, 2018 - 2030 (Volume, Units; Revenue, USD Million)
  • 7.9.5. Kuwait
    • 7.9.5.1. Key Country Dynamics
    • 7.9.5.2. Competitive Scenario
    • 7.9.5.3. Regulatory Framework
    • 7.9.5.4. Reimbursement scenario
    • 7.9.5.5. Kuwait Gynecological Chairs and Tables Market Estimates and Forecasts, 2018 - 2030 (Volume, Units; Revenue, USD Million)

Chapter 8. Competitive Landscape

• 8.1. Market Participant Categorization
• 8.2. Key Company Profiles
  • 8.2.1. STERIS
    • 8.2.1.1. Company overview
    • 8.2.1.2. Financial performance
    • 8.2.1.3. Product benchmarking
    • 8.2.1.4. Strategic initiatives
  • 8.2.2. Optomic
    • 8.2.2.1. Company overview
    • 8.2.2.2. Financial performance
    • 8.2.2.3. Product benchmarking
    • 8.2.2.4. Strategic initiatives
  • 8.2.3. medifa
    • 8.2.3.1. Company overview
    • 8.2.3.2. Financial performance
    • 8.2.3.3. Product benchmarking
    • 8.2.3.4. Strategic initiatives
  • 8.2.4. Advin Health Care
    • 8.2.4.1. Company overview
    • 8.2.4.2. Financial performance
    • 8.2.4.3. Product benchmarking
    • 8.2.4.4. Strategic initiatives
  • 8.2.5. MERIVAARA CORP.
    • 8.2.5.1. Company overview
    • 8.2.5.2. Financial performance
    • 8.2.5.3. Product benchmarking
    • 8.2.5.4. Strategic initiatives
  • 8.2.6. Apothecaries Sundries Manufacturing Co.
    • 8.2.6.1. Company overview
    • 8.2.6.2. Financial performance
    • 8.2.6.3. Product benchmarking
    • 8.2.6.4. Strategic initiatives
  • 8.2.7. Novak M.
    • 8.2.7.1. Company overview
    • 8.2.7.2. Financial performance
    • 8.2.7.3. Product benchmarking
    • 8.2.7.4. Strategic initiatives
  • 8.2.8. Zhangjiagang Medi Medical Equipment Co., ltd.
    • 8.2.8.1. Company overview
    • 8.2.8.2. Financial performance
    • 8.2.8.3. Product benchmarking
    • 8.2.8.4. Strategic initiatives
  • 8.2.9. Surgitech
    • 8.2.9.1. Company overview
    • 8.2.9.2. Financial performance
    • 8.2.9.3. Product benchmarking
    • 8.2.9.4. Strategic initiatives
  • 8.2.10. The Brewer Company, LLC
    • 8.2.10.1. Company overview
    • 8.2.10.2. Financial performance
    • 8.2.10.3. Product benchmarking
    • 8.2.10.4. Strategic initiatives
  • 8.2.11. Midmark Corporation. (Ritter Midmark)
    • 8.2.11.1. Company overview
    • 8.2.11.2. Financial performance
    • 8.2.11.3. Product benchmarking
    • 8.2.11.4. Strategic initiatives
  • 8.2.12. Clinton Industries, Inc.
    • 8.2.12.1. Company overview
    • 8.2.12.2. Financial performance
    • 8.2.12.3. Product benchmarking
    • 8.2.12.4. Strategic initiatives
  • 8.2.13. UMF Medical
    • 8.2.13.1. Company overview
    • 8.2.13.2. Financial performance
    • 8.2.13.3. Product benchmarking
    • 8.2.13.4. Strategic initiatives
  • 8.2.14. Hausmann Enterprises, LLC
    • 8.2.14.1. Company overview
    • 8.2.14.2. Financial performance
    • 8.2.14.3. Product benchmarking
    • 8.2.14.4. Strategic initiatives
  • 8.2.15. Bailey's Medical Supplies
    • 8.2.15.1. Company overview
    • 8.2.15.2. Financial performance
    • 8.2.15.3. Product benchmarking
    • 8.2.15.4. Strategic initiatives
  • 8.2.16. Metron Healthcare
    • 8.2.16.1. Company overview
    • 8.2.16.2. Financial performance
    • 8.2.16.3. Product benchmarking
    • 8.2.16.4. Strategic initiatives
  • 8.2.17. Baxter (Hill Rom Holdings)Company overview
    • 8.2.17.1. Financial performance
    • 8.2.17.2. Product benchmarking
    • 8.2.17.3. Strategic initiatives

관련자료